Dixon Jonathan V. reported BNGO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001967837-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 2, 2026

Published

Feb 4, 2026

Ingested by INSIDER

Nov 5, 04:19 UTC

Last re-read

Nov 5, 04:19 UTC

Extracted facts

Filer

Dixon Jonathan V.

Role

GENERAL COUNSEL

Transaction

Grant or awardAs filed: “A”

Asset

Bionano Genomics, Inc. — Stock Option (Right to Buy)

Ticker

BNGO

Shares

26.1K

Price per share

$0

Execution date (reported)

Feb 2, 2026

Owned after transaction

26.1K shares

Days from execution to publication

2

What this establishes

Dixon Jonathan V. filed this Form 4 reporting a grant or award of BNGO on Feb 2, 2026. It became public on Feb 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

GENERAL COUNSEL

Dixon Jonathan V.cik:0001967837

Issuer

Bionano Genomics, Inc.cik:0001411690

Revision history · 0

No field has changed since this record was first ingested.